SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Profiteer who wrote (2698)7/7/1998 7:20:00 PM
From: Profiteer  Read Replies (2) of 5402
 
Hi Folks: The meeting went well and as Prospector & Gwolf have stated it will take time to pass on the information. Dr. Drees has agreed to answer all your question submitted to him by Prospector. So please be patient. I will try and pass on segments of the meeting as fast as I can, but please do not ask me to answer questions. I'm no doctor and will be the first to admit it. I can only relay what was said. If you disagree strongly with it, please call Dr. Drees and ask for an explanation. Thank you.

Some of the opening statements of Dr. Drees:

Oxygen Therapeutic packed red blood cells would be Dr. Drees's preferred description of PHER-02, rather then Artificial blood. It picks up oxygen in your lungs takes it through the heart and carries it through your body, giving up oxygen and starts picking up Carbon dioxide. It returns to the lungs where it gets rid of CO2 by exhaling. You do not metabolize this product!

The most important therapy for PHER-02 will be transfusions. Because it treats and replaces the lack of oxygen in the body, anytime there is a disease that has lack of oxygen connected with it, PHER-02 has the potential of being a cure for that disease. That includes, heart attack, stroke, cancer, sicklecell anemia, eye problems, shock, burn victims and others. There are about 150 applications that they are aware of.

So this will not end up being a ONE PRODUCT company. The world of medicine badly need a transfusion material that has a longer life than six weeks, ours has a 3 year shelf life, 27 times longer.

MORE TO COME..
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext